Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Kyobu Geka. the Japanese Journal of Thoracic Surgery|June 1, 2012
[Acute aortic dissection with anomalous coronary artery]Takako Nishino, Toshihiko Saga, Hitoshi Kitayama, et al.
Scandinavian Cardiovascular Journal : SCJ|August 16, 2005
Antegrade selective cerebral perfusion with mild hypothermic systemic circulatory arrest during thoracic aortic surgeryToshio Kaneda, Toshihiko Saga, Masahiko Onoe, et al.
Oncotarget|February 10, 2011
A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugsRyuya Murai, Yoko Yoshida, Teruyuki Muraguchi, et al.
The Journal of Biological Chemistry|November 22, 2008
RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectinAkira Omura, Tomoko Matsuzaki, Kazuhiro Mio, et al.
Nature|February 3, 2006
Functional genomics reveals genes involved in protein secretion and Golgi organizationFrederic Bard, Laetitia Casano, Arrate Mallabiabarrena, et al.
Neuroscience Letters|October 6, 2009
Transplantation of cultured choroid plexus epithelial cells via cerebrospinal fluid shows prominent neuroprotective effects against acute ischemic brain injury in the ratNaoya Matsumoto, Akihiko Taguchi, Hitoshi Kitayama, et al.
Journal of Cell Science|February 15, 2007
Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cellsShunya Kondo, Chisa Shukunami, Yoko Morioka, et al.
Archives of Gerontology and Geriatrics|November 21, 2009
VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: a multicenter experienceKazuyoshi Ishii, Fumiaki Urase, Yasuaki Nagare, et al.
Cancer Research|December 18, 2004
Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECKJunseo Oh, Dong-Wan Seo, Tere Diaz, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2005
[VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report]Kazuyoshi Ishii, Yoshihisa Yamamoto, Takashi Shigeki, et al.
Pageof 4